New Market Study, "South Korea Pharmaceuticals & Healthcare Report Q2 2014", Has Been Published
We highlight that, despite challenging conditions, South Korea does offer some form of certainty given that the government has yet to initiate fresh rounds of extensive medicine price cuts, providing short-term stability to the pharmaceutical market. Stringent price containment goes against the country's aim to develop its pharmaceutical sector, and therefore in order to foster the sector's growth, potential changes must be made to drug pricing regulation, representing an upside risk to our outlook.
View full press release